CAREGEN CO.,LTD. Logo

CAREGEN CO.,LTD.

Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.

214370 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 엘에스로91번길 46-38, 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Caregen Co., Ltd., established in 2001, is a global biotechnology company specializing in the research, development, and commercialization of biomimetic peptides and growth factors. As a leader in peptide synthesis, the company leverages its proprietary platform technologies and an extensive portfolio of patented peptides. Caregen develops and manufactures innovative products, including cosmeceuticals and dermal fillers, for the medical aesthetics and pharmaceutical markets. Its core research focuses on applications such as anti-aging solutions and hair regrowth treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 54.0 KB
2025-09-08 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 38.5 KB
2025-08-18 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 11.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-12 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.9 KB
2025-08-12 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2025-08-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 6.3 KB
2025-07-15 00:00
Report Publication Announcement
[기재정정]기업설명회(IR)개최
Korean 10.6 KB
2025-07-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-07-04 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (중간배당)
Korean 8.6 KB
2025-06-26 00:00
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (CGP5 펩타이드 기반 신약 후보물질의 제1상 임상시험계…
Korean 25.2 KB
2025-06-13 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.7 KB
2025-05-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-13 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.9 KB
2025-05-13 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB

Automate Your Workflow. Get a real-time feed of all CAREGEN CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CAREGEN CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.